A Novel Targeting Therapy of Malignant Mesothelioma Using Anti-Podoplanin AntibodyShinji Abe, Yasuhiko Nishioka, Yuki Morita et al.|The Journal of Immunology|2013Cited by 91
HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibodyWei Wang, Saburo Sone, Yasuhiko Nishioka et al.|Cancer Immunology Immunotherapy|2008Cited by 64
Surfactant Protein A Suppresses Lung Cancer Progression by Regulating the Polarization of Tumor-Associated MacrophagesAtsushi Mitsuhashi, Yasuhiko Nishioka, Hisatsugu Goto et al.|American Journal Of Pathology|2013Cited by 63
The chimeric antibody chLpMab-7 targeting human podoplanin suppresses pulmonary metastasis via ADCC and CDC rather than via its neutralizing activityYukinari Kato, Mika K. Kaneko, Akiko Kunita et al.|Oncotarget|2015Cited by 62
Antitumor effect of novel anti‐podoplanin antibody NZ‐12 against malignant pleural mesothelioma in an orthotopic xenograft modelShinji Abe, Yasuhiko Nishioka, Mika K. Kaneko et al.|Cancer Science|2016Cited by 62